Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for CorMedix (CRMD) over the last 7 years, with Q2 2025 value amounting to $71.9 million.

  • CorMedix's Shares Outstanding (Diluted Average) rose 2481.33% to $71.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $71.9 million, marking a year-over-year increase of 2481.33%. This contributed to the annual value of $58.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Shares Outstanding (Diluted Average) of $71.9 million as of Q2 2025, which was up 2481.33% from $69.0 million recorded in Q1 2025.
  • CorMedix's Shares Outstanding (Diluted Average)'s 5-year high stood at $71.9 million during Q2 2025, with a 5-year trough of $37.7 million in Q4 2021.
  • Over the past 5 years, CorMedix's median Shares Outstanding (Diluted Average) value was $44.7 million (recorded in 2023), while the average stood at $49.6 million.
  • Per our database at Business Quant, CorMedix's Shares Outstanding (Diluted Average) skyrocketed by 3731.97% in 2023 and then soared by 401.75% in 2024.
  • Quarter analysis of 5 years shows CorMedix's Shares Outstanding (Diluted Average) stood at $37.7 million in 2021, then increased by 6.92% to $40.3 million in 2022, then surged by 40.42% to $56.6 million in 2023, then increased by 4.1% to $58.9 million in 2024, then grew by 22.16% to $71.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $71.9 million in Q2 2025, compared to $69.0 million in Q1 2025 and $58.9 million in Q4 2024.